Daily News Podcast

Statin effect in prostate cancer may be caused by reduced inflammation


 

Long-term use of statins may protect against lethal forms of prostate cancer by altering the inflammatory profile of the tumor microenvironment. Also today, Verma unveils Medicaid scorecard but refuses to judge efforts, the AMA reports that opioid prescriptions are down since 2013, and a prior knee injury creates a ‘distinct group’ in osteoarthritis.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Psoriasis therapy with biologics not linked to increased cancer risk
MDedge Internal Medicine
High testosterone in postmenopausal women may add CVD risk
MDedge Internal Medicine
Endocrinologists well positioned to be experts on changes in transgender care
MDedge Internal Medicine
ACS: Screen for colon cancer at 45
MDedge Internal Medicine
First antidepressant use not tied to first abortion
MDedge Internal Medicine
TAILORx: Most women with intermediate risk ER+ breast cancer can safely skip chemo
MDedge Internal Medicine
Hydroxychloroquine throws off Quantiferon-TB Gold results, study finds
MDedge Internal Medicine
What is causing my patients’ macrocytosis?
MDedge Internal Medicine
Hip pain predicts arthritis mortality beyond comorbidities
MDedge Internal Medicine
Prostate cancer risk before age 55 higher for black men
MDedge Internal Medicine